Premier Biomedical, Inc. (BIEI)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
+0.0001 (20.00%)
Jan 21, 2025, 4:00 PM EST
Premier Biomedical Revenue
In the year 2019, Premier Biomedical had annual revenue of $14.28K, down -64.11%. Premier Biomedical had revenue of $1.31K in the quarter ending December 31, 2019, a decrease of -85.63%.
Revenue
14.28K
Revenue Growth
-64.11%
P/S Ratio
2.02
Revenue / Employee
3.57K
Employees
4
Market Cap
604.38K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
Premier Biomedical News
- 2 months ago - Premier Graphene Completes Joint Venture with Leading Technology and Systems Development Company Isatek S.A. de C.V. - GlobeNewsWire
- 5 months ago - Premier Graphene's Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests - GlobeNewsWire
- 7 months ago - Premier Graphene, Inc. Ships Advanced Graphene Suspension Samples to Global Leader in Essential Materials - GlobeNewsWire
- 2 years ago - Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology - GlobeNewsWire